Phase I Trial of Everolimus, Gemcitabine, and Cisplatin for Patients With Solid Tumors Refractory to Standard Therapy
Phase of Trial: Phase I
Latest Information Update: 16 Jan 2017
At a glance
- Drugs Cisplatin (Primary) ; Everolimus (Primary) ; Gemcitabine (Primary)
- Indications Cholangiocarcinoma; Gallbladder cancer
- Focus Adverse reactions
- 11 Jan 2017 Status changed from active, no longer recruiting to completed.
- 20 Dec 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
- 07 Jan 2016 Planned primary completion date changed from 1 Sep 2015 to 1 Sep 2016 as reported by ClinicalTrials.gov.